Author:
Caminero Luna José,Migliori Giovanni Battista
Publisher
Springer International Publishing
Reference12 articles.
1. Caminero JA, Scardigli A, van der Werf T, Tadolini M. Treatment of drug-susceptible and drug-resistant tuberculosis. In: Migliori GB, Bothamley G, Duarte R, Rendon A, editors. Tuberculosis (ERS monograph). Sheffield: European Respiratory Society; 2018. p. 152–78. https://doi.org/10.1183/2312508X.10021417.
2. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946–1986, with relevant subsequent publications. Int J Tuberc Lung Dis. 1999;3(Suppl. 2):S231–79.
3. Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, et al. Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines. Clin Infect Dis. 2015;61(Suppl 3):S102–18. https://doi.org/10.1093/cid/civ609.
4. Caminero JA, Van Deun A, Fujiwara PI, et al. Guidelines for clinical and operational management of drug-resistant tuberculosis. Paris: IUATLD; 2013.
5. Caminero JA, Cayla JA, García-García JM, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J. Diagnosis and treatment of drug-resistant tuberculosis. Arch Bronconeumol. 2017;53:501–9.